Search research articles
Contact Us
Filters
Showing results (241-250 of 697) with videos related to
Page
of 70
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 17, 2022
Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer
Shounak Majumder, William R Taylor, Patrick H Foote, et al.
American Journal of Human Genetics
|
February 4, 2018
Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches
Lucia Guidugli, Hermela Shimelis, David L Masica, et al.
Breast Cancer Research and Treatment
|
January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2
Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
Nature Communications
|
November 22, 2017
Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
Latha Kadalayil, Sofia Khan, Heli Nevanlinna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen
Matthew P Goetz, Vera J Suman, James N Ingle, et al.
Human Mutation
|
March 12, 2011
Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary
Phillip J Whiley, Lucia Guidugli, Logan C Walker, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 4, 2018
Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels
Kristy Lee, Bryce A Seifert, Hermela Shimelis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 10, 2018
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models
Steven N Hart, Tanya Hoskin, Hermela Shimelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging
Rajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.
Journal of the National Cancer Institute
|
November 7, 2020
Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea
Kathryn J Ruddy, Daniel J Schaid, Anthony Batzler, et al.
Page
of 70
Search research articles
Search
Showing results (241-250 of 697) with videos related to
Sort By:
Page
of 70
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 17, 2022
Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer
Shounak Majumder, William R Taylor, Patrick H Foote, et al.
American Journal of Human Genetics
|
February 4, 2018
Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches
Lucia Guidugli, Hermela Shimelis, David L Masica, et al.
Breast Cancer Research and Treatment
|
January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2
Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
Nature Communications
|
November 22, 2017
Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
Latha Kadalayil, Sofia Khan, Heli Nevanlinna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen
Matthew P Goetz, Vera J Suman, James N Ingle, et al.
Human Mutation
|
March 12, 2011
Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary
Phillip J Whiley, Lucia Guidugli, Logan C Walker, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 4, 2018
Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels
Kristy Lee, Bryce A Seifert, Hermela Shimelis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
June 10, 2018
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models
Steven N Hart, Tanya Hoskin, Hermela Shimelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging
Rajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.
Journal of the National Cancer Institute
|
November 7, 2020
Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea
Kathryn J Ruddy, Daniel J Schaid, Anthony Batzler, et al.
Page
of 70